ATH-1017, as Fosgonimeton, Seen to Aid Neurons and Motor Function
Early studies in nerve cells and a rat model of Parkinson’s disease support the potential of fosgonimeton, also known…
Articles by Patricia Inácio, PhD
Cannabinoid Program Launches for Neurodegenerative Diseases
InMed Pharmaceuticals will launch a new program – the INM-900 series – that will investigate the therapeutic potential of…
Dosing Begins in Phase 1 Clinical Trial of AAV-GAD Gene Therapy
MeiraGTx’s new Phase 1/2 clinical trial of AAV-GAD, its investigational gene therapy for Parkinson’s disease, has…
LRRK2 Gene Variant in Parkinson’s Tied to Novel Cell Death Mechanism
A specific mutation in the LRRK2 gene — whose variants are often associated with Parkinson’s disease – renders immune…
Algorithm to ID Voice Changes May Aid in Early Detection of Parkinson’s
A new machine-learning algorithm — a type of artificial intelligence or AI — that integrates facial expression and voice recordings…
Chemical Exposure Is Key Risk Factor for Parkinson’s, Scientists Say
New scientific evidence supports a link between exposure to toxic environmental factors — pesticides, air pollutants, man-made materials, and more…
Enterin, Parkinson’s UK Planning Trial of ENT-01 in Easing Dementia
Enterin has teamed with Parkinson’s UK to launch a Phase 2 trial evaluating the ability of ENT-01, its investigational…
COGNISANT Boosts Short-term Memory in Older Adults: Study
A new strategy that combines online cognitive therapeutic games with a noninvasive brain stimulation technique – called COGNISANT – may…
At-home Digital Cameras Monitor Gait, May Speed Diagnosis
Researchers have developed a software that can accurately identify people with Parkinson’s disease or multiple sclerosis (MS) from…
MJFF Grant Supports Research of Brain Inflammation
Muna Therapeutics has received a $4.9 million grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to advance…